マーケットレポート詳細
ゲノム編集の世界市場：2028年に至る製品サービス別、技術別予測
Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application (Cell Line Engineering, Genetic Engineering, Drug Discovery), End User (Pharma, Biotech) – Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年 7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文 209ページになります。
- 商品コード：MAM3331
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
ゲノム編集の世界市場規模は2023年で53億ドル、2028年までに106億ドルへと急拡大し、市場の平均年成長率は15%で推移することが見込まれています。
レポートはゲノム編集の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品/サービス別市場、技術別市場、等）を中心に構成されています。また競合状況、主要企業情報（19社）、市場ダイナミクス、サプライチェーン分析などの分析も加味し、ゲノム編集市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆ゲノム編集の世界市場予測2021-2028年
・市場規模(US$)
◆製品/サービス別、市場-2028年
・試薬/消耗品
・ソフトウェア/システム
・サービス
※(市場規模US$)
◆技術別、市場-2028年
・CRISPR
・TALEN
・ZFN
・アンチセンス
・その他技術
※(市場規模US$)
◆用途別、市場-2028年
・細胞株エンジニアリング
・遺伝子工学
・創薬、医薬品開発
・その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・製薬/バイオテクノロジー企業
・学術/研究機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
・ブラジル
・その他中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・サプライチェーン分析
・バリューチェーン分析
・価格分析
・規制分析
・エコシステム分析
・業界構造分析（ファイブフォース分析）
・競合状況
・市場シェア分析
◆ゲノム編集の主要企業プロフィール動向
・THERMO FISHER SCIENTIFIC
・MERCK KGAA
・GENSCRIPT
・AGILENT TECHNOLOGIES
・PERKINELMER
・LONZA
・TECAN LIFE SCIENCES
・SANGAMO THERAPEUTICS
・EDITAS MEDICINE
・CRISPR THERAPEUTICS AG
・PRECISION BIOSCIENCES
・CELLECTIS S.A.
・INTELLIA THERAPEUTICS
・BLUEBIRD BIO INC.
・REGENERON PHARMACEUTICALS INC.
・AMSBIO
・CREATIVE BIOGENE
・SYNTHEGO CORPORATION
・BEAM THERAPEUTICS
（その他企業）
・CARIBOU BIOSCIENCES
・ORIGENE TECHNOLOGIES
・NEW ENGLAND BIOLABS
・INSCRIPTA
・MAMMOTH BIOSCIENCES
（全209頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS 32
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 2 BREAKDOWN OF PRIMARIES: GENE EDITING MARKET
2.2 MARKET ESTIMATION METHODOLOGY
・ FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
・ FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
・ FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
・ FIGURE 6 GENE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
・ FIGURE 7 GENE EDITING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 DATA TRIANGULATION
・ FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
・ TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 9 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 10 GENE EDITING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 GENE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENE EDITING MARKET, 2022
4 PREMIUM INSIGHTS
4.1 GENE EDITING MARKET OVERVIEW
・ FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
・ FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 NORTH AMERICA GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 16 CELL LINE ENGINEERING TO DOMINATE NORTH AMERICAN MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 17 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 GENOME EDITING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 RISING GOVERNMENT FUNDING AND NUMBER OF GENOMICS PROJECTS
5.2.1.2 GROWING APPLICATIONS OF GENOMICS
5.2.1.3 INTRODUCTION OF CRISPR-CAS9
5.2.2 RESTRAINTS
5.2.2.1 OFF-TARGET EFFECTS OF CRISPR TECHNOLOGY
5.2.3 OPPORTUNITIES
5.2.3.1 EXTENSIVE USE OF GENOME EDITING IN PERSONALIZED MEDICINE
5.2.3.2 EXPANDING PIPELINE FOR GENE THERAPY
5.2.4 CHALLENGES
5.2.4.1 HIGH EQUIPMENT COSTS
5.3 TECHNOLOGY ANALYSIS
5.4 SUPPLY AND VALUE CHAIN ANALYSIS
5.4.1 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
・ FIGURE 18 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
5.4.2 VALUE CHAIN ANALYSIS
・ FIGURE 19 GENE EDITING MARKET: VALUE CHAIN ANALYSIS
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.6 PRICING ANALYSIS
・ TABLE 5 AVERAGE SELLING PRICES, BY PRODUCT (KEY PLAYER OFFERINGS)
5.7 REGULATORY ANALYSIS
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 ECOSYSTEM ANALYSIS
・ FIGURE 21 GENE EDITING MARKET: ECOSYSTEM ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 11 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS 67
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY CONFERENCES AND EVENTS IN 2023
・ TABLE 12 GENE EDITING MARKET: CONFERENCES AND EVENTS (2023)
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 22 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.11.2 GENE EDITING MARKET: BUYING CRITERIA
・ FIGURE 23 KEY BUYING CRITERIA FOR GENE EDITING
5.12 PATENT ANALYSIS
・ FIGURE 24 PATENTS GRANTED, JANUARY 2011–JUNE 2023
・ FIGURE 25 TOP PATENT APPLICANTS, JANUARY 2011–JUNE 2023
6 GENE EDITING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
・ TABLE 13 GENE EDITING MARKET, BY PRODUCT & SERVICE,
2021–2028 (USD MILLION)
6.2 REAGENTS & CONSUMABLES
6.2.1 REAGENTS & CONSUMABLES TO HOLD LARGEST MARKET SHARE
・ TABLE 14 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 15 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73
・ TABLE 16 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 17 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
・ TABLE 18 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
6.3 SOFTWARE & SYSTEMS
6.3.1 INCREASING APPLICATIONS OF GENOME EDITING/SEQUENCING TO BOOST DEMAND FOR SYSTEMS AND SOFTWARE
・ TABLE 19 GENE EDITING SOFTWARE & SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 20 NORTH AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 21 EUROPE: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 22 ASIA PACIFIC: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 23 LATIN AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 RISING DEMAND FOR SERVICES TO SUPPORT GROWTH
・ TABLE 24 GENE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 25 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 26 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 27 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 28 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 GENE EDITING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
・ TABLE 29 GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 CRISPR
7.2.1 EASE OF USE TO BOOST DEMAND OVER OTHER TECHNOLOGIES
・ TABLE 30 GENE EDITING MARKET FOR CRISPR, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 31 NORTH AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 32 EUROPE: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 33 ASIA PACIFIC: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 34 LATIN AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TALEN
7.3.1 ABILITY TO MAKE QUICK MODIFICATIONS TO DRIVE USAGE
・ TABLE 35 GENE EDITING MARKET FOR TALEN, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 36 NORTH AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 37 EUROPE: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 38 ASIA PACIFIC: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 39 LATIN AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 ZFN
7.4.1 UTILITY IN EUKARYOTE CELL STUDIES TO DRIVE MARKET GROWTH
・ TABLE 40 GENE EDITING MARKET FOR ZFN, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 41 NORTH AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 42 EUROPE: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 43 ASIA PACIFIC: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 44 LATIN AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 ANTISENSE 86
7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
・ TABLE 45 GENE EDITING MARKET FOR ANTISENSE, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 46 NORTH AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 EUROPE: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 48 ASIA PACIFIC: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 49 LATIN AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER TECHNOLOGIES
・ TABLE 50 GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 51 NORTH AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 52 EUROPE: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 53 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 54 LATIN AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
8 GENE EDITING MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 55 GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 CELL LINE ENGINEERING
8.2.1 INCREASING RESEARCH APPLICATIONS TO PROMOTE MARKET GROWTH
・ TABLE 56 GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 57 NORTH AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 EUROPE: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 59 ASIA PACIFIC: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 60 LATIN AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 GENETIC ENGINEERING
8.3.1 GROWING USE OF ANIMAL SIMULATION MODELS IN RESEARCH AND INCREASING INTEREST IN GM CROPS TO DRIVE MARKET
・ TABLE 61 GENE EDITING MARKET FOR GENETIC ENGINEERING, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 62 NORTH AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 EUROPE: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 64 ASIA PACIFIC: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 65 LATIN AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 DRUG DISCOVERY & DEVELOPMENT
8.4.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO BOOST GROWTH
・ TABLE 66 GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 67 NORTH AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 68 EUROPE: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98
・ TABLE 69 ASIA PACIFIC: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 70 LATIN AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER APPLICATIONS
・ TABLE 71 GENE EDITING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 72 NORTH AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 73 EUROPE: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 74 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 75 LATIN AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 GENE EDITING MARKET, BY END USER 102
9.1 INTRODUCTION
・ TABLE 76 GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE
・ TABLE 77 GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 78 NORTH AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 79 EUROPE: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 80 ASIA PACIFIC: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 81 LATIN AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 TREND OF COLLABORATIVE RESEARCH TO SUPPORT MARKET GROWTH
・ TABLE 82 GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 83 NORTH AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 84 EUROPE: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107
・ TABLE 85 ASIA PACIFIC: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 86 LATIN AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 OTHER END USERS
・ TABLE 87 GENE EDITING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 88 NORTH AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 89 EUROPE: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 90 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 91 LATIN AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 GENE EDITING MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 92 GENE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
・ FIGURE 26 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
・ TABLE 93 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 94 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 95 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 96 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 97 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 US
10.2.2.1 ROBUST INVESTMENT TO DRIVE MARKET GROWTH
・ TABLE 98 US: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 99 US: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 100 US: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 101 US: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 AVAILABILITY OF RESEARCH FUNDING TO SUPPORT GROWTH
・ TABLE 102 CANADA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 103 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 104 CANADA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 105 CANADA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
・ TABLE 106 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 107 EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 108 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 109 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 110 EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 STRONG ACADEMIC BASE AND RISING AWARENESS TO BOOST MARKET
・ TABLE 111 GERMANY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 112 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 113 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 114 GERMANY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 UK
10.3.3.1 GOVERNMENT SUPPORT TO BOOST MARKET GROWTH
・ TABLE 115 UK: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 116 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 117 UK: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 118 UK: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 GOVERNMENT FUNDING FOR GENOMICS AND RISING RESEARCH INVESTMENTS TO PROPEL MARKET
・ TABLE 119 FRANCE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 120 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 121 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 122 FRANCE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 ITALY
10.3.5.1 INCREASING COLLABORATIONS TO DRIVE GENOMIC MEDICINE RESEARCH AND FAVOR MARKET
・ TABLE 123 ITALY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 124 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 125 ITALY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 126 ITALY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 PROACTIVE RESEARCH FUNDING TO BOOST MARKET
・ TABLE 127 SPAIN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 128 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 129 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 130 SPAIN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
・ TABLE 131 REST OF EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 132 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 133 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 134 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
・ FIGURE 27 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
・ TABLE 135 ASIA PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 136 ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 137 ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 138 ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 139 ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 CHINA TO HOLD LARGEST SHARE OF APAC MARKET
・ TABLE 140 CHINA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 141 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 142 CHINA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 143 CHINA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 FOCUS ON CANCER RESEARCH TO SHOWCASE FAVORABLE SCENARIOS FOR GENE EDITING MARKET
・ TABLE 144 JAPAN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 145 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 146 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 147 JAPAN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 INDIA
10.4.4.1 GROWING STARTUPS AND GOVERNMENT SUPPORT TO BOOST GROWTH POTENTIAL
・ TABLE 148 INDIA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 149 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 150 INDIA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 151 INDIA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
・ TABLE 152 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 153 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 154 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 155 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
・ TABLE 156 LATIN AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 157 LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 158 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 159 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 160 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 BRAZIL TO DOMINATE LATIN AMERICAN MARKET
・ TABLE 161 BRAZIL: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 162 BRAZIL: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 163 BRAZIL: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 164 BRAZIL: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
・ TABLE 165 REST OF LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 166 REST OF LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 167 REST OF LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 168 REST OF LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 MIDDLE EAST & AFRICA
10.5.4.1 INCREASING ADOPTION OF GENETIC TESTING TO PROPEL MARKET
10.5.5 MIDDLE EAST & AFRICA: RECESSION IMPACT
・ TABLE 169 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 170 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 171 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 172 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
・ FIGURE 28 KEY PLAYER STRATEGIES, 2020–2023
11.3 MARKET SHARE ANALYSIS
・ TABLE 173 GENE EDITING MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・ FIGURE 30 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (2020–2022)
11.5 COMPANY EVALUATION QUADRANT, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 EMERGING COMPANIES
・ FIGURE 31 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT, 2022
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
・ FIGURE 32 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
11.7 COMPANY FOOTPRINT ANALYSIS
11.7.1 PRODUCT/SERVICE FOOTPRINT ANALYSIS
・ TABLE 174 PRODUCT/SERVICE FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022)
11.7.2 GEOGRAPHIC FOOTPRINT ANALYSIS
・ TABLE 175 GEOGRAPHIC FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022)
11.8 COMPETITIVE SCENARIO
12 COMPANY PROFILES
12.1 KEY COMPANIES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 THERMO FISHER SCIENTIFIC
・ TABLE 176 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
・ FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.2 MERCK KGAA
・ TABLE 177 MERCK KGAA: BUSINESS OVERVIEW
・ FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.3 GENSCRIPT
・ TABLE 178 GENSCRIPT: BUSINESS OVERVIEW 169
・ FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2022)
12.1.4 AGILENT TECHNOLOGIES
・ TABLE 179 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
・ FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2022)
12.1.5 PERKINELMER
・ TABLE 180 PERKINELMER: BUSINESS OVERVIEW
・ FIGURE 37 PERKINELMER: COMPANY SNAPSHOT (2022)
12.1.6 LONZA
・ TABLE 181 LONZA: BUSINESS OVERVIEW
・ FIGURE 38 LONZA: COMPANY SNAPSHOT (2022)
12.1.7 TECAN LIFE SCIENCES
・ TABLE 182 TECAN LIFESCIENCES: BUSINESS OVERVIEW
・ FIGURE 39 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2022)
12.1.8 SANGAMO THERAPEUTICS
・ TABLE 183 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW
・ FIGURE 40 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.1.9 EDITAS MEDICINE
・ TABLE 184 EDITAS MEDICINE: BUSINESS OVERVIEW
・ FIGURE 41 EDITAS MEDICINE: COMPANY SNAPSHOT (2022)
12.1.10 CRISPR THERAPEUTICS AG
・ TABLE 185 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW
・ FIGURE 42 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2022)
12.1.11 PRECISION BIOSCIENCES
・ TABLE 186 PRECISION BIOSCIENCES: BUSINESS OVERVIEW
・ FIGURE 43 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020)
12.1.12 CELLECTIS S.A.
・ TABLE 187 CELLECTIS: BUSINESS OVERVIEW 194
・ FIGURE 44 CELLECTIS: COMPANY SNAPSHOT (2022)
12.1.13 INTELLIA THERAPEUTICS
・ TABLE 188 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW
・ FIGURE 45 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.1.14 BLUEBIRD BIO INC.
・ TABLE 189 BLUEBIRD BIO: BUSINESS OVERVIEW
・ FIGURE 46 BLUEBIRD BIO: COMPANY SNAPSHOT (2022)
12.1.15 REGENERON PHARMACEUTICALS INC.
・ TABLE 190 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW
・ FIGURE 47 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2022)
12.1.16 AMSBIO
・ TABLE 191 AMSBIO: BUSINESS OVERVIEW
12.1.17 CREATIVE BIOGENE
・ TABLE 192 CREATIVE BIOGENE: BUSINESS OVERVIEW
12.1.18 SYNTHEGO CORPORATION
・ TABLE 193 SYNTHEGO CORPORATION: BUSINESS OVERVIEW
12.1.19 BEAM THERAPEUTICS
・ TABLE 194 BEAM THERAPEUTICS: BUSINESS OVERVIEW
・ FIGURE 48 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
12.2.1 CARIBOU BIOSCIENCES
12.2.2 ORIGENE TECHNOLOGIES
12.2.3 NEW ENGLAND BIOLABS
12.2.4 INSCRIPTA
12.2.5 MAMMOTH BIOSCIENCES
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS